NYMOX PHARMACEUTICAL CORP (NYMX)
BSP733981026 - Common Stock
Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial Results
NYMOZARFEX 15 mg Minimal Treatment of Low Grade Prostate Cancer Leads to Significant Long-Term Reduction in Incidence of Associated Prostate Cancer Surgery and Radiotherapy
Nymox Reports on U.S. Patent Issuances
Nymox Update
Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of Nymox
NYMOX Update
Why Is Kazia Therapeutics (KZIA) Stock Moving Today?
Kazia Therapeutics (KZIA) stock is on the move Thursday after the company received fast-track designation for its paxalisib program.
Why Is Nymox Pharmaceutical (NYMX) Stock Down 18% Today?
Nymox Pharmaceutical (NYMX) stock is falling on Thursday after the company told investors its shares will be delisted tomorrow.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start the day off right with a breakdown of the biggest pre-market stock movers traders need to watch on Thursday!
Nymox Delisting from NASDAQ
Nymox Delisting from NASDAQ
IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) today received a Nasdaq Hearing Delist...
Nymox Provides Current Update
Nymox Provides Current Update
IRVINE, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a mid-2nd quarter...
Nymox Provides Corporate Update
Nymox Provides Corporate Update
IRVINE, Calif., April 03, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to provide a current update...
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer
Nymox Announces Appointment of Christopher R. Riley as Chief Financial Officer
IRVINE, Calif., March 21, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce the appointment...
Nymox Pharmaceutical gets additional time to regain Nasdaq compliance (NASDAQ:NYMX)
Nymox Pharmaceutical (NYMX) has been granted an additional period until July 3, 2023 to regain compliance with Nasdaq listing requirements. The firm expects to announce further...
Nymox Officially Granted Extension to Regain Listing Requirements
Nymox Officially Granted Extension to Regain Listing Requirements
IRVINE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) has officially been granted by NASDAQ...
Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review
Nymox Announces NYMOZARFEX Marketing Application is Accepted For Review
IRVINE, Calif., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) is pleased to announce that the...